Ultragenyx Pharmaceutical
RARE
#3817
Rank
โ‚น289.31 B
Marketcap
โ‚น2,999
Share price
2.01%
Change (1 day)
-18.00%
Change (1 year)

EPS for Ultragenyx Pharmaceutical (RARE)

EPS in 2025 (TTM): -โ‚น514.52

According to Ultragenyx Pharmaceutical's latest financial reports the company's current EPS (TTM) is -โ‚น531.73. In 2024 the company made an earnings per share (EPS) of -โ‚น567.54 an increase over its 2023 EPS that were of -โ‚น745.68.

EPS history for Ultragenyx Pharmaceutical from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น514.52-9.34%
2024-โ‚น567.54-23.89%
2023-โ‚น745.68-17.61%
2022-โ‚น905.0250.67%
2021-โ‚น600.66113.69%
2020-โ‚น281.08-55.9%
2019-โ‚น637.3682.56%
2018-โ‚น349.12-45.15%
2017-โ‚น636.4714.68%
2016-โ‚น555.01
2014-โ‚น207.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
BioMarin Pharmaceutical
BMRN
โ‚น243.49-145.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-โ‚น9.85-98.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น44.76-91.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚น17.01-96.80%๐Ÿ‡บ๐Ÿ‡ธ USA